Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT
- 1 March 1997
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 349 (9053) , 667-674
- https://doi.org/10.1016/s0140-6736(96)09145-3
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Does amiodarone reduce sudden death and cardiac mortality after myocardial infarction?European Heart Journal, 1994
- The European Myocardial Infarct Amiodarone Trial (EMIAT)The American Journal of Cardiology, 1993
- Effect of amiodarone on mortality after myocardial infarction: A double-blind, placebo-controlled, pilot studyJournal of the American College of Cardiology, 1992
- Effect of the Antiarrhythmic Agent Moricizine on Survival after Myocardial InfarctionNew England Journal of Medicine, 1992
- Post-myocardial infarction mortality in patients with ventricular premature depolarizations. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Pilot Study.Circulation, 1991
- Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel antiarrhythmic study of infarct survival (BASIS)Journal of the American College of Cardiology, 1990
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Prophylactic antiarrhythmic therapy of high-risk survivors of myocardial infarction: lower mortality at 1 month but not at 1 year.Circulation, 1987
- International mexiletine and placebo antiarrhythmic coronary trial: I. Report on arrhythmia and other findingsJournal of the American College of Cardiology, 1984
- Effect of antiarrhythmic drugs on mortality after myocardial infarctionThe American Journal of Cardiology, 1983